ArticleNeuro-oncology2017

The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity.

Jeffrey A Rubens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.